Financial insights of ADIA

MyFinsight

Income Statement	2026-06-30	2026-03-31	2025-12-31
Total revenue	485,385	176,275	175,127*
Total revenue-Supplements	-	-	323.75*
Supplements	0	0	-
Total revenue-Procedures	-	-	54,488.75*
Procedures	82,588	70,962	-
Total revenue-Biologics	-	-	72,397*
Biologics	120,217	37,736	-
Total cost of revenue	202,805	108,698	127,209.5*
Gross profit	282,580	67,577	47,917.5*
General and administrative	23,175	33,778	12,847.25*
Advertising and promotion	22,436	37,007	19,551.75*
Clinical trial fees	7,175	4,850	1,725*
Corporate filings	-	4,005	4,627.5*
Corporate filing fees	7,723	-	-
Equipment leases	6,696	6,696	7,946*
Legal and professional fees	81,922	78,809	34,506.5*
Public relations	2,480	-	-
Repairs and maintenance	1,152	-	672*
Public relations	-	2,440	4,198.75*
Repairs and maintenance	-	1,010	1,321*
Rent	19,748	16,183	16,159*
Research and development	0	-	7,286*
Salaries and wages	55,129	32,602	15,441.75*
Shared-based compensation	-	-	10,562.5*
Utilities	1,672	866	1,585.75*
Depreciation and amortization	1,443	1,251	1,109.75*
Total operating expenses	230,751	219,497	139,540.5*
Income (loss) from operations	51,829	-151,920	-91,623*
Interest income	375	375	156.25*
Sublease income	-	-	500*
Interest expense related party	11,786	10,980	7,899.25*
Total other income (expense)	-11,411	-10,605	-7,243*
Net income (loss) before provision for income taxes	40,418	-162,525	-98,866*
Provision for income taxes	0	0	0*
Net income (loss)	40,418	-162,525	-98,866

Basic EPS	0	0	-0.001
Diluted EPS	0	0	-0.001
Basic Average Shares	94,404,696	94,404,696	93,596,730
Diluted Average Shares	161,404,696	94,404,696	93,596,730

Unit: Dollar. Numbers labeled with * are estimated quarterly values.